» Authors » Natasa Karas Kuzelicki

Natasa Karas Kuzelicki

Explore the profile of Natasa Karas Kuzelicki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 134
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kek T, Gersak K, Kuzelicki N, Sturm D, Mazej D, Tratnik J, et al.
Biol Trace Elem Res . 2025 Mar; PMID: 40056357
No abstract available.
2.
Kilianova Z, Stollarova N, Pivackova L, Krenek P, Goboova M, Rihova Z, et al.
Pharmacogenomics . 2025 Feb; 25(16-18):667-678. PMID: 39916529
Aim: This study is designed to address the connection between antidepressant and antipsychotic-induced hepatotoxicity with pharmacogenetic and epigenetic indicators, using a novel combined approach of CYP450 polymorphism determination and early...
3.
Kek T, Gersak K, Kuzelicki N, Sturm D, Mazej D, Tratnik J, et al.
Biol Trace Elem Res . 2025 Jan; PMID: 39789351
Premature ovarian insufficiency (POI) is poorly understood, with causes identified in only 25% of cases. Emerging evidence suggests links between trace elements (TEs) and POI. This study is the first...
4.
Kuzelicki N, Smid A, Vidmar Golja M, Kek T, Eberlinc A, Gersak B, et al.
Birth Defects Res . 2024 Oct; 116(11):e2408. PMID: 39473220
Background: Uninterrupted folate metabolism plays a vital role in embryonic development, ensuring a supply of one-carbon-activated folate cofactors for essential processes. Folate deficiency has been implicated in the development of...
5.
Smid A, Urbancic D, Zlajpah J, Stollarova N, Prelog T, Kavcic M, et al.
Pharmacogenomics . 2024 Oct; 25(12-13):515-525. PMID: 39453028
Determining variant alleles to predict patient response to thiopurine therapy represents one of the first successful implementations of pharmacogenomics in clinical practice. However, despite the -adjusted thiopurine dosing, some wild-type...
6.
Kuzelicki N, Doljak B
Genes (Basel) . 2024 Jul; 15(7). PMID: 39062651
Congenital heart disease is one of the most common congenital malformations and thus represents a considerable public health burden. Hence, the identification of individuals and families with an increased genetic...
7.
Smid A, Stajdohar M, Milek M, Urbancic D, Kuzelicki N, Tamm R, et al.
Eur J Pharm Sci . 2023 Oct; 192:106616. PMID: 37865284
Thiopurine S-methyltransferase (TPMT) is an important enzyme involved in the deactivation of thiopurines and represents a major determinant of thiopurine-related toxicities. Despite its well-known importance in thiopurine metabolism, the understanding...
8.
Slavec L, Gersak K, Eberlinc A, Hovnik T, Lovrecic L, Mlinaric-Rascan I, et al.
Int J Mol Sci . 2023 Mar; 24(5). PMID: 36901693
Although the aetiology of non-syndromic orofacial clefts (nsOFCs) is usually multifactorial, syndromic OFCs (syOFCs) are often caused by single mutations in known genes. Some syndromes, e.g., Van der Woude syndrome...
9.
Osredkar J, Gersak Z, Kuzelicki N, Tratnik J, Mazej D, Falnoga I, et al.
Nutrients . 2022 Nov; 14(21). PMID: 36364931
Trace elements, including zinc (Zn) and copper (Cu), are known to play important roles in human health. The present study aimed to assess the levels of Zn and Cu in...
10.
Kuzelicki N, Smid A, Vidmar Golja M, Kek T, Gersak B, Mazic U, et al.
J Cardiovasc Dev Dis . 2022 Jun; 9(6). PMID: 35735795
Several environmental and genetic factors may influence the risk of congenital heart defects (CHDs), which can have a substantial impact on pediatric morbidity and mortality. We investigated the association of...